San Diego-primarily based Viking Therapeutics marked itself as a serious competitor while in the weight loss drug marketplace in February right after revealing promising knowledge from the mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection As well as in Mar